Zenotech Laboratories

Zenotech Laboratories Interest Expense

The Interest Expense of Zenotech Laboratories (532039.BO) as of Nov 16, 2026 is 14.09 M INR. In the previous year, Interest Expense was 9.45 M INR — a change of 49.08% (higher).

Interest Expense

14.09 MINR

YoY

49.08%

Last updated:

Interest Expense of Zenotech Laboratories is 2025 14.09 M INR. Interest Expense of Zenotech Laboratories was 2024 9.45 M INR. It decreases by 49.08% higher compared to the previous year.

The Zenotech Laboratories Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2018
-7.28 M INR
Jan 1, 2019
10.06 M INR
Jan 1, 2020
445,000.00 INR
Jan 1, 2021
-14.93 M INR
Jan 1, 2022
-11.19 M INR
Jan 1, 2023
2.56 M INR
Jan 1, 2024
9.45 M INR
Jan 1, 2025
14.09 M INR
The Zenotech Laboratories Interest Expense history
YEARInterest ExpenseYoY
14.09 MINR+49.08%
9.45 MINR+269.61%
2.56 MINR-122.84%
-11.19 MINR-25.02%
-14.93 MINR-3,454.61%
445,000.00INR-95.58%
10.06 MINR-238.28%
-7.28 MINR-90.30%
-75.00 MINR-0.51%
-75.39 MINR+13.42%
-66.47 MINR+42.03%
-46.80 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Interest Expense of Zenotech Laboratories is 14.09 M INR in 2025.

Interest Expense of Zenotech Laboratories changed from 9.45 M INR to 14.09 M INR, representing a 49.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories